Targeting the mitochondrial VDAC in hepatocellular carcinoma using a polyclonal antibody-conjugated to a nitrosyl ruthenium complex

Loyanne Carla Barbosa Ramos; Fernando Postalli Rodrigues; Juliana C. Biazzotto; Sérgio de Paula Machado; Leonardo D. Slep; Michael R Hamblin; Roberto Santana da Silva

doi:10.1007/s00775-018-1589-x

Back

Targeting the mitochondrial VDAC in hepatocellular carcinoma using a polyclonal antibody-conjugated to a nitrosyl ruthenium complex

Article 2018 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Chapter in a book2007

Molecular Targeting in Hepatocellular Carcinoma

Jonathan D. Schwartz, Josep M. Llovet

Article2025

984P FIPO23: A first-in-human trial of XON7, a Glyco-Humanized Polyclonal Antibody (GHpAb)targeting multiple tumor antigens in advanced solid tumors

J. Bennouna, Françoise Shneiker, Jean Yves Blay, J.P. Delord, M. Brahmi, Firas Bassissi, Raffaele Ratta, Carlos Gomez‐Roca, Philippe A. Cassier, Asmahane Benmaziane, Christiane Jungels, Iphigénie Korakis, Ahmad Awada

Article2022

A brightly red emissive AIEgen and its antibody conjugated nanoparticles for cancer cell targeting imaging

Huifang Su, Ziwei Deng, Yanling Liu, Yun Zhao, Hongjian Liu, Zheng Zhao, Ben Zhong Tang

Article2012

Induction of hepatocellular carcinoma by in vivo gene targeting

Pei-Rong Wang, Mei Xu, Sara Toffanin, Yi Li, Josep M. Llovet, David W. Russell

Proceedings of the National Academy of Sciences

Article2012

314 INDUCTION OF HEPATOCELLULAR CARCINOMA BY IN VIVO GENE TARGETING

P.-R. Wang, Minhui Xu, S. Toffanin, Y. Li, Helena Cornellà, Josep M. Llovet, David W. Russell

Journal of Hepatology